Companies

Outlook Therapeutics, Inc. (OTLK) SEC filings

CIK 0001649989 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 09/30

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)1.4 M
Net income (USD)-62.4 M-59.0 M-66.1 M
Diluted EPS (USD/shares)-1.79-4.72-0.31

Latest filings

FiledFormDescriptionPeriod
2026-10-13SCHEDULE 13GSCHEDULE 13G
2026-09-308-KFORM 8-K items 3.012026-09-25
2026-09-188-KFORM 8-K items 8.012026-09-16
2026-09-02442026-09-01
2026-09-02332026-09-01
2026-08-278-KFORM 8-K items 5.02,9.012026-08-23
2026-08-19SCHEDULE 13GSCHEDULE 13G
2026-08-1810-Q10-Q2026-06-30
2026-08-17NT 10-QNT 10-Q2026-06-30
2026-08-144OWNERSHIP DOCUMENT2026-08-14
2026-08-14SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-144FORM 42026-08-12
2026-08-144PRIMARY DOCUMENT2026-08-14
2026-08-148-KFORM 8-K items 8.01,9.012026-08-12
2026-08-14424B5424B5
2026-08-148-KFORM 8-K items 2.02,9.012026-08-14
2026-08-12424B5424B5
2026-08-128-KFORM 8-K items 2.02,8.01,9.012026-08-12
2026-07-294PRIMARY DOCUMENT2026-07-29
2026-07-248-KFORM 8-K items 8.01,9.012026-07-24
2026-07-248-KFORM 8-K items 5.022026-07-21
2026-07-234PRIMARY DOCUMENT2026-07-21
2026-07-234PRIMARY DOCUMENT2026-07-21
2026-07-21EFFECTEFFECT items ,,
2026-07-21424B3424B3

Forms on file (last 1,000): 4 266, 8-K 176, 3 32, 10-Q 32, 424B3 32, CORRESP 28, SC 13D/A 23, EFFECT 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=OTLK (0.002 USD), /gw/filings/filings?ticker=OTLK&form=8-K, /gw/filings/facts?ticker=OTLK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange